Cardinal Health (CAH) FCF Margin (2009 - 2026)
Cardinal Health's (CAH) quarterly FCF Margin came in at 2.75% in Q1 2026, down 234.0% year-on-year from 2.05% in Q1 2025, and up 225.4% quarter-over-quarter from 0.85% in Q4 2025.
Cardinal Health (CAH) FCF Margin (2009 - 2026) Analysis & Trends
Cardinal Health has disclosed FCF Margin across 18 years of filings, most recently posting 2.75% for Q1 2026.
- FCF Margin for Q1 2026 came in at 2.75%, down 234.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.75% (up 65.0% YoY), and the FY2025 annual result was 0.83%, down 60.0% from the prior year.
- FCF Margin came in at 2.75% for Q1 2026 at Cardinal Health, up from 0.85% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 6.12% in Q2 2022 to a low of 3.32% in Q3 2024.
- The 5-year median for FCF Margin is 1.21% (2023), against an average of 1.36%.
- Across the five-year window, FCF Margin plunged 491 bps in 2023 and soared 534 bps in 2025, its largest moves.
- Cardinal Health's FCF Margin stood at 0.99% in 2022, then jumped by 86 bps to 1.85% in 2023, then slumped by 148 bps to 0.9% in 2024, then soared by 194 bps to 0.85% in 2025, then surged by 225 bps to 2.75% in 2026.
- The last three FCF Margin figures came in at 2.75% (Q1 2026), 0.85% (Q4 2025), and 1.35% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 3.48% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 1.50% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 2.75% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -3.62% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | -19.45% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -18.96% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 1.06% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -6.02% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.75% |
| Dec 31, 2025 | 0.85% |
| Sep 30, 2025 | 1.35% |
| Jun 30, 2025 | 2.14% |
| Mar 31, 2025 | 5.09% |
| Dec 31, 2024 | -0.90% |
| Sep 30, 2024 | -3.32% |
| Jun 30, 2024 | 3.16% |
| Mar 31, 2024 | -0.25% |
| Dec 31, 2023 | 1.85% |
| Sep 30, 2023 | 0.80% |
| Jun 30, 2023 | 1.21% |
| Mar 31, 2023 | 2.48% |
| Dec 31, 2022 | 0.99% |
| Sep 30, 2022 | -0.09% |
| Jun 30, 2022 | 6.12% |
| Mar 31, 2022 | -1.12% |
| Dec 31, 2021 | 2.47% |
| Sep 30, 2021 | -1.62% |
| Jun 30, 2021 | 1.27% |